SULFAMYLON CREAM Rx
Generic Name and Formulations:
Mafenide acetate 85mg (base); crm; contains parabens, sodium metabisulfite.
Indications for SULFAMYLON CREAM:
Adjunct in 2nd and 3rd degree burns.
Adults and Children:
Apply 1–2 times daily aseptically with approximately 1/16 inch depth to cleansed and debrided burns. Ensure coverage of burned areas at all times; reapply promptly if removed. May be occluded with a thin layer of dressing, if needed. Continue until wound is healed or site is ready for grafting. Withhold therapy for 24–48 hours if acidosis occurs.
G6PD deficiency. Sulfite sensitivity. Asthma. Acute renal failure. Monitor acid-base balance closely (esp. with extensive 2nd degree or partial thickness burns, pulmonary or renal impairment). Pregnancy (Cat.C); (crm: not recommended for women of childbearing potential; unless burn area >20% of total body surface). Nursing mothers: not recommended.
Application-site pain, burning sensation, allergic manifestations (eg, rash, pruritus, facial edema, swelling, erythema; discontinue if occur), tachypnea, hyperventilation, metabolic acidosis; respiratory alkalosis, fatal hemolytic anemia with disseminated intravascular coagulation, fungal colonization; rare: excoriation of new skin, bleeding of skin.
Crm—2oz, 4oz, 16oz
Renal and Urology News Articles
- Novel Albuminuria Endpoints May Improve CKD Progression Trials
- Comorbidities Adversely Linked to Cancer Trial Participation
- Global Demand for Bladder Cancer Treatment Threatens Supply in 2019
- Opioids Now More Deadly for Americans Than Traffic Accidents
- New Predictor of In-Hospital Acute Kidney Injury Identified
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)